Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wadler

Showing results (101-110 of 140) with videos related to

Pageof 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Activity and pharmacodynamics of 21-Day topotecan infusion in patients with ovarian cancer previously treated with platinum-based chemotherapy. New York Gynecologic Oncology GroupH Hochster, S Wadler, C Runowicz, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Phase II trial of N-(phosphonacetyl)-L-aspartate (PALA), 5-fluorouracil and recombinant interferon-alpha-2b in patients with advanced gastric carcinomaS Wadler, B Gleissner, R U Hilgenfeld, et al.
Gynecologic Oncology|June 1, 1996
Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervixA L Fields, P S Anderson, G L Goldberg, et al.
Cancer|July 1, 1996
Phase II clinical trial with 5-fluorouracil, recombinant interferon-alpha-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagusS Wadler, H Haynes, J J Beitler, et al.
Gynecologic Oncology|March 4, 1999
A phase II double-blind randomized study of the simultaneous administration of recombinant human interleukin-6 and recombinant human granulocyte colony-stimulating factor following paclitaxel and carboplatin chemotherapy in patients with advanced epithelial ovarian cancerH Hochster, J L Speyer, J P Mandeli, et al.
Investigational New Drugs|January 1, 1997
An ECOG phase II study of amonafide in unresectable or recurrent carcinoma of the head and neck (PB390). Eastern Cooperative Oncology GroupA N Leaf, D Neuberg, E L Schwartz, et al.
Cancer|September 15, 1994
Utility of embolization or chemoembolization as second-line treatment in patients with advanced or recurrent colorectal carcinomaD J Martinelli, S Wadler, C W Bakal, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Phase II trial of echinomycin in patients with advanced or recurrent colorectal cancerS Wadler, L Tenteromano, L Cazenave, et al.
Investigational New Drugs|September 20, 2001
N-Methylformamide in advanced squamous cancer of the uterine cervix: an Eastern Cooperative Oncology Group phase II trialL Rajdev, Z F Yu, S Wadler, et al.
Gynecologic and Obstetric Investigation|July 8, 1999
Krukenberg tumors: can management be improved?F M McGill, D B Ritter, C S Rickard, et al.
Pageof 14

Showing results (101-110 of 140) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Activity and pharmacodynamics of 21-Day topotecan infusion in patients with ovarian cancer previously treated with platinum-based chemotherapy. New York Gynecologic Oncology GroupH Hochster, S Wadler, C Runowicz, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Phase II trial of N-(phosphonacetyl)-L-aspartate (PALA), 5-fluorouracil and recombinant interferon-alpha-2b in patients with advanced gastric carcinomaS Wadler, B Gleissner, R U Hilgenfeld, et al.
Gynecologic Oncology|June 1, 1996
Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervixA L Fields, P S Anderson, G L Goldberg, et al.
Cancer|July 1, 1996
Phase II clinical trial with 5-fluorouracil, recombinant interferon-alpha-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagusS Wadler, H Haynes, J J Beitler, et al.
Gynecologic Oncology|March 4, 1999
A phase II double-blind randomized study of the simultaneous administration of recombinant human interleukin-6 and recombinant human granulocyte colony-stimulating factor following paclitaxel and carboplatin chemotherapy in patients with advanced epithelial ovarian cancerH Hochster, J L Speyer, J P Mandeli, et al.
Investigational New Drugs|January 1, 1997
An ECOG phase II study of amonafide in unresectable or recurrent carcinoma of the head and neck (PB390). Eastern Cooperative Oncology GroupA N Leaf, D Neuberg, E L Schwartz, et al.
Cancer|September 15, 1994
Utility of embolization or chemoembolization as second-line treatment in patients with advanced or recurrent colorectal carcinomaD J Martinelli, S Wadler, C W Bakal, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Phase II trial of echinomycin in patients with advanced or recurrent colorectal cancerS Wadler, L Tenteromano, L Cazenave, et al.
Investigational New Drugs|September 20, 2001
N-Methylformamide in advanced squamous cancer of the uterine cervix: an Eastern Cooperative Oncology Group phase II trialL Rajdev, Z F Yu, S Wadler, et al.
Gynecologic and Obstetric Investigation|July 8, 1999
Krukenberg tumors: can management be improved?F M McGill, D B Ritter, C S Rickard, et al.
Pageof 14